Explore groundbreaking studies, clinical trial updates, and emerging technologies shaping the future of cancer treatment.
Exploring predictive biomarkers for lenvatinib and pembrolizumab response in endometrial cancer patients, including NLR, CD20+ B cells, and KEYNOTE-146 findings.